Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP896174.RAguFnGyn_S-bDJIpho04PCF79bOPz18ERlKM5KT5SPh8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP896174.RAguFnGyn_S-bDJIpho04PCF79bOPz18ERlKM5KT5SPh8130_assertion type Assertion NP896174.RAguFnGyn_S-bDJIpho04PCF79bOPz18ERlKM5KT5SPh8130_head.
- NP896174.RAguFnGyn_S-bDJIpho04PCF79bOPz18ERlKM5KT5SPh8130_assertion description "[In estrogen receptor (ER?+) human breast cancer cells, melatonin suppresses both ER? mRNA expression and estrogen-induced transcriptional activity of the ER? via MT(1) -induced activation of G(?i2) signaling and reduction of 3',5'-cyclic adenosine monophosphate (cAMP) levels.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP896174.RAguFnGyn_S-bDJIpho04PCF79bOPz18ERlKM5KT5SPh8130_provenance.
- NP896174.RAguFnGyn_S-bDJIpho04PCF79bOPz18ERlKM5KT5SPh8130_assertion evidence source_evidence_literature NP896174.RAguFnGyn_S-bDJIpho04PCF79bOPz18ERlKM5KT5SPh8130_provenance.
- NP896174.RAguFnGyn_S-bDJIpho04PCF79bOPz18ERlKM5KT5SPh8130_assertion SIO_000772 21605163 NP896174.RAguFnGyn_S-bDJIpho04PCF79bOPz18ERlKM5KT5SPh8130_provenance.
- NP896174.RAguFnGyn_S-bDJIpho04PCF79bOPz18ERlKM5KT5SPh8130_assertion wasDerivedFrom befree-2016 NP896174.RAguFnGyn_S-bDJIpho04PCF79bOPz18ERlKM5KT5SPh8130_provenance.
- NP896174.RAguFnGyn_S-bDJIpho04PCF79bOPz18ERlKM5KT5SPh8130_assertion wasGeneratedBy ECO_0000203 NP896174.RAguFnGyn_S-bDJIpho04PCF79bOPz18ERlKM5KT5SPh8130_provenance.